Related Experiment Video
Updated: Aug 11, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Parkinson's disease management strategies
1Royal University Hospital, Saskatchewan, S7N 0W8, Canada. rajputa@sask.usask.ca
Expert Review of Neurotherapeutics
|February 10, 2006
Summary
Parkinson's disease (PD) management requires individualized treatment plans, prioritizing long-term symptom control and quality of life. Levodopa is a key drug, with surgery as an option for specific patients.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder requiring long-term management.
- Current drug therapies aim to control symptoms but have limitations, including adverse effects and reduced efficacy over time.
Purpose of the Study:
- To outline individualized treatment strategies for Parkinson's disease.
- To discuss the rationale behind specific treatment choices based on patient factors.
Main Methods:
- Review of current pharmacological and surgical treatment options for PD.
- Emphasis on individualized patient assessment considering age, symptoms, and quality of life.
Main Results:
- Drug therapy is the primary treatment, with a stepwise approach often starting with less potent medications.
- Levodopa remains the most effective drug, typically reserved for later stages.
- Surgical options like subthalamic nucleus deep-brain stimulation are considered for select patients.
Conclusions:
- No single treatment is perfect; individualized care and regular medication adjustments are crucial.
- Treatment goals include maintaining low disability levels and minimizing adverse effects.
- Therapeutic approaches must balance efficacy with long-term patient well-being.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications